Tag: biopharma

With no vendors or booths, the summit continues to facilitate an open exchange of ideas, foster collaboration, and promote thought leadership

The Cover Story focuses on the impact of BIOE3 policy. Read Special Interview of Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research. Expert Insights by Dr Prabhu Vinayagam, Medical Advisor, Orchid AMS and Shashank Avadhani, CEO and Co-founder, Alyve Health. Special stories on MPox virus, AMR and AgriTech.

ADCs have become a focal point in oncology due to their ability to selectively target cancer cells, resulting in reduced off-target side effects.

Under this agreement, CDRI and Zydus will jointly undertake preclinical research. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets

HANSIZHUANG (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC

In an exclusive interview, Siddharth Daga, Managing Director, VINS Bioproducts shared his views on his company’s operations, product portfolio, latest industry trends and outlook

Biopharmaceutical companies are now focusing on advancing these drugs to enhance efficacy and expand their therapeutic scope beyond type 2 diabetes and obesity

The Cover Story focuses on India's crucial role in ensuring global vaccine security with an exclusive interview of Dr Krishna Ella, Executive Chairman, Bharat Biotech & President, Indian Vaccine Manufacturers Association. Read interviews of Sriram Natarajan, CEO, Molbio Diagnostics and Dr Renuka Diwan, CEO, BioPrime Agrisolutions. Also features Expert Insights, Special Story and Startup Special.

Recognition of Avantor's achievements in downstream processing, single-use systems, and its overall leadership as a biopharma supplier in Korea

Bharat Biotech's collaboration with MSD, Wellcome-Trust Hilleman Laboratories aims to address the critical shortage of OCVs